Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027847
Filing Date
2024-11-27
Accepted
2024-11-27 16:15:12
Documents
1
Period of Report
2024-11-25

Document Format Files

Seq Description Document Type Size
1 form4-11272024_041107.html 4  
1 form4-11272024_041107.xml 4 4696
  Complete submission text file 0001415889-24-027847.txt   6271
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TOURMALINE BIO, INC. 27 WEST 24TH STREET, SUITE 702 NEW YORK NY 10010
Business Address
Thiara Parvinder (Reporting) CIK: 0001995535 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40598 | Film No.: 241511359